Compounds of formula 1 or pharmaceutically acceptable salts thereof are
provided: 1
which are agonists and partial agonists of the 2c subtype of brain
serotonin receptors. The compounds, and compositions containing the
compounds, can be used to treat a variety of central nervous system
disorders such as schizophrenia.
